Validated using a knockout cell line
Recombinant
RabMAb

Recombinant Anti-Cyclin D2 antibody [EPR19659] (ab207604)

Publishing research using ab207604? Please let us know so that we can cite the reference in this datasheet.

ab207604 has been referenced in 8 publications.

  • Yao Y  et al. miR-671-3p is downregulated in non-small cell lung cancer and inhibits cancer progression by directly targeting CCND2. Mol Med Rep 19:2407-2412 (2019). PubMed: 30664171
  • Zhou X  et al. UCA1 promotes cell viability, proliferation and migration potential through UCA1/miR-204/CCND2 pathway in primary cystitis glandularis cells. Biomed Pharmacother 114:108872 (2019). PubMed: 30999112
  • Caller LG  et al. Temporal Proteomic Analysis of BK Polyomavirus Infection Reveals Virus-Induced G2 Arrest and Highly Effective Evasion of Innate Immune Sensing. J Virol 93:N/A (2019). PubMed: 31142673
  • Jiang D  et al. Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1. J Cell Physiol N/A:N/A (2019). PubMed: 31304601
  • Chen H  et al. RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line. Int J Mol Sci 20:N/A (2019). PubMed: 31311113
  • Yao S  et al. MicroRNA-376a regulates cell proliferation and apoptosis by targeting forkhead box protein P2 in lymphoma. Oncol Lett 16:3169-3176 (2018). PubMed: 30127911
  • Hu W  et al. MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells. Biomed Pharmacother 105:887-898 (2018). PubMed: 30021382
  • Anton L  et al. miR-143 and miR-145 disrupt the cervical epithelial barrier through dysregulation of cell adhesion, apoptosis and proliferation. Sci Rep 7:3020 (2017). PubMed: 28596604

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up